Montefiore-Einstein News & Stories

Healthcare workers, academic and medical researchers, colleagues, community and other New York heroes — here are their stories and latest news.

El Dr. Barry Zingman de Montefiore-Einstein habla en News12BX sobre el ensayo de la vacuna del COVID-19

Montefiore-Einstein's Dr. Barry Zingman Speaks to News12BX About COVID-19 Vaccine Trial

Dr. Sharma Speaks to US News About COVID-19 and Signs & Symptoms of Infant Heart Failure

Dr. Sharma Speaks to US News About COVID-19 and Signs & Symptoms of Infant Heart Failure

New Study & Recommendation for Statin Use in Diabetics with COVID-19

New Study & Recommendation for Statin Use in Diabetics with COVID‑19

Montefiore-Einstein Talks to the NY Times About How Children Fight Off COVID-19

Montefiore-Einstein Talks to the NY Times About How Children Fight Off COVID‑19

Dr. Zingman, Clinical Director, Infectious Diseases and Professor of Medicine, Montefiore-Einstein discusses the health system's efforts to ensure communities hit hardest by COVID-19 - people of color, health care workers, and people over 65 - are included in the AstraZeneca vaccine trial. Watch the full segment here.

An infant diagnosed with COVID‑19 showed signs of reversible heart injury and heart failure, according to a new case report by lead author Dr. Madhu Sharma, a pediatric cardiologist at the Children's Hospital at Montefiore.

Montefiore-Einstein’s Ulrich P. Jorde, MD, Vice Chief, Division of Cardiology, senior author of the study shares principal finding that statin use was associated with a dramatically reduced risk of death from COVID‑19 in hospitalized patients with diabetes.

Dr. Aluko Hope, Co-director, COVID-19 Recovery (CORE) Clinic and Associate Professor, Montefiore-Einstein speaks to NPR about coronavirus "long-haulers," and the prolonged or new symptoms that may occur months after getting COVID‑19.

Betsy Herold, Chief of Pediatric Infectious Diseases and Vice Chair for Pediatric Research at Montefiore and Einstein, speaks to the NY Times about her new research that may help explain why COVID‑19 affects kids less severely.

The FDA has approved the antiviral drug remdesivir (brand name: Veklury), for the treatment of hospitalized #COVID19 patients. “The approval of Veklury marks an important milestone in efforts to help address the pandemic by offering an effective treatment that helps patients recover faster,” said Montefiore-Einstein's Barry Zingman, MD, Director, Infectious Diseases, Moses Division, Montefiore Health System about the new approval.

Dr. Philip Ozuah shares his hope that during this moment, people will fight to eradicate racism while also working to end the coronavirus pandemic.

We are open for elective surgeries and procedures. For everyone’s safety, we have designated treatment areas for non-COVID-19 patients, and we have gone beyond industry standards to implement the most rigorous COVID-SAFE Care protocols currently available. Now more than ever, it’s important to not put your healthcare needs on hold.

Out-of-hospital heart attacks in NYC nearly tripled during the height of the COVID-19 pandemic—peaking on April 6, 2020 with 305 cases, an almost 10x increase from the same day in 2019—according to a study published in JAMA Cardiology by Dr. David Prezant of Montefiore, Albert Einstein College of Medicine and FDNY.

Former professional cyclist, John Loehner, MD, an internal medicine physician and medical director at Montefiore Health System's Moses Campus, shares his experience on the frontline of the COVID-19 pandemic and how cycling has been key in helping him weather this storm.

Montefiore’s Chief Psychologist, Dr. Simon Rego discusses the psychological impact of the COVID-19 lockdown and having a lack of “social rhythm reinforcers” like school, social events or the gym.

In Dr. Ozuah’s NYT op-ed, he writes: “I see rare hope that these twin disasters disproportionately hurting minorities — one a brand-new virus and the other a virus as old as the country itself — could finally prove the true strength of our shared humanity.”

Montefiore-Einstein's research reveals nearly all newborns born to COVID-19-positive mothers tested negative for the disease immediately after birth, according to the largest body of data in the U.S. about pregnant women & COVID.

Dr. Teresa Hsu-Walklet, Supervising Psychologist, Behavioral Health Integration Program (BHIP) at Children's Hospital at Montefiore, spoke to Bronx Times about how COVID-19 has affected children and parents. She says families should seek the treatment and support needed.

Dr. H. Michael Ushay of Children’s Hospital at Montefiore tells NY1 that Montefiore-Einstein has seen 37 Multisystem Inflammatory Syndrome in Children (MIS-C) patients, most of whom have been discharged, and the most reassuring aspect of the illness is how well children respond to treatment.

In the midst of a pandemic that has paralyzed the world, a CBS News team spent 7 days on the frontline at Montefiore-Einstein capturing the bravery and hope of our healthcare heroes who have been courageously fighting COVID-19.

Montefiore-Einstein's Dr. Nir Barzilai tells the NY Times that while vulnerability to COVID-19 increases at around age 55, older adults can slow or reverse their declining immune defenses with an improved diet and exercise regimen.

Dr. Nadine Choueiter of Children’s Hospital at Montefiore speaks to NBC New York about rare cases of Pediatric Multisystem Inflammatory Syndrome (PMIS) related to COVID-19 and the importance of identifying symptoms so it can be treated.

Following promising results from NIH’s remdesivir trial, Montefiore-Einstein has begun testing a new drug combination as the next stage of the Adaptive COVID-19 Treatment Trial (ACTT2) — remdesivir and baricitinib. This may be the key to treating the most severe COVID-19 cases.

Music therapy is helping to heal patients and staff at Children’s Hospital at Montefiore during COVID-19. Annalissa Vicencio, MA, MT-BC, Music Therapist, uses music to bring wellness and enhance the lives of patients, their families and her colleagues as well.

The Department of Pediatrics at Montefiore-Einstein conducted the largest single-center U.S. study researching how children are affected by COVID-19. While most children infected with COVID-19 have mild symptoms, a small number experience a severe response.

Dr. Philip O. Ozuah, CEO of Montefiore Medicine, spoke to MSNBC’s Morning Joe about testing, clinical trials, and the heroic fight, praising the courageous frontline workers at Montefiore.

Montefiore-Einstein's Dr. Barry Zingman, Clinical Director, Infectious Diseases and Professor of Medicine, Montefiore-Einstein joined JakeTapper on CNN to share early findings on the remdesivir trial he's leading.

New York Times' Nicholas Kristof tells the compelling story of Montefiore's ER Doctor Andres Maldonado who was diagnosed with COVID-19 and brought to the ICU after treating patients on the frontlines of the pandemic.

Researchers at Montefiore-Einstein conducted the largest study so far to assess outcomes for patients with cancer who have also been infected with #COVID19. The study, published in the online edition of Cancer Discovery, provides guidance on how to help protect this vulnerable patient population.

Can blood taken from people who have recovered from COVID-19 treat the virus? Montefiore-Einstein is teaming up with NYU Langone to study how COVID-19 survivors can aid current COVID-19 patients. Convalescent plasma may be the answer.

Montefiore-Einstein, one of the locations participating in the remdesivir clinical trial, has enrolled 91 patients in the study to test its effectiveness in treating #COVID19. Dr. Barry Zingman, Clinical Director, Infectious Diseases and Professor of Medicine, discusses promising early findings of remdesivir trial with NBC.

Doctors from Montefiore Health System applied for an emergency grant to purchase essential items such as diapers, wipes and formula for patient care packages. News 12 The Bronx highlights our #Monteheroes' efforts to get critical items directly to mothers and their babies in need amid the #COVID19 crisis.

Nicholas Kristof of the NYT tells the story of COVID-19 through the lens of humanity, as told to him by Montefiore heroes. He reports from the frontline on the stark reality of suffering, while showing the compassion, courage and heroism that brings light to this unprecedented time.

Why do men infected by COVID-19 generally show more severe symptoms and why are they are more likely than women to die from the virus? Researchers at Montefiore-Einstein showed for the first time that men clear the virus from their bodies slower than women. The explanation: a potential male-only “reservoir” for coronavirus.

Dr. Liise-anne Pirofski, Chief of Infectious Disease, Department of Medicine at Montefiore Health System, speaks to CNN about a new clinical trial to treat individuals infected with COVID-19.

Montefiore heroes read aloud an inspirational letter from their boss Dr. Scott Melvin, Vice Chair of Clinical Surgery. Filled with words of wisdom and hope, this motivational rally is defined by perseverance and bravery, during a moment in time we'll never forget.

In an exclusive interview, Dr. Theresa Madaline, takes CNN inside Montefiore New Rochelle Hospital. Dr. Madaline discusses the severity and impact of COVID-19, as well as how they will prepare for what's to come.

Trusted Information Resources

Centers for Disease Control and Prevention

The leading national public health institute of the United States
 

NY.gov

For the latest COVID-19 guidelines and information from New York State 

World Health Organization

UN agency responsible for international public health